Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
10.58
+0.13 (1.20%)
At close: Nov 20, 2024, 4:00 PM
10.25
-0.33 (-3.12%)
After-hours: Nov 20, 2024, 7:17 PM EST
Indivior Employees
Indivior had 1,164 employees as of December 31, 2023. The number of employees increased by 236 or 25.43% compared to the previous year.
Employees
1,164
Change (1Y)
236
Growth (1Y)
25.43%
Revenue / Employee
$1,015,464
Profits / Employee
-$2,577
Market Cap
1.33B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pediatrix Medical Group | 5,450 |
| Tilray Brands | 2,650 |
| Novavax | 1,543 |
| Alphatec Holdings | 839 |
| Rocket Pharmaceuticals | 268 |
| Kura Oncology | 142 |
| Mesoblast | 73 |
| Enliven Therapeutics | 46 |
INDV News
- 1 day ago - Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 - PRNewsWire
- 13 days ago - Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior - PRNewsWire
- 21 days ago - Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - PRNewsWire
- 27 days ago - Indivior PLC (INDV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Indivior Announces Q3 2024 Financial Results - PRNewsWire
- 5 weeks ago - Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025 - Seeking Alpha
- 6 weeks ago - British drugmaker Indivior cuts 2024 revenue forecast, shares fall - Reuters
- 6 weeks ago - Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion - PRNewsWire